VSee Health, Inc.

VSEED Healthcare Health Information Services

In the quarter to June 2026, revenue grew 48.0%, EPS grew 106.3%, free cash flow fell 257.6% and total debt rose 31.6%, each against the same quarter a year earlier.

1.88 0.01 −0.53%
Market cap
$2.8M
P/E
0.0×
Fwd P/E
−2.2×
Dividend yield
—
F-score
4/9
Altman Z
−6.33
Beneish M
−4.22
Dividend safety
n/a

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 0.00%

Capital & Financial Ratios $m

Market Cap 2.80
Revenue 14.96
Net Income (9.89)
Free Cash Flow (6.31)
Net Debt 0.33
Current Ratio 0.40 (below 1: weak)
Debt/Equity 0.10 (at or below 0.5: strong)
P/E ratio 0.00
Fwd P/E (2.17) (negative: loss-making)
P/S ratio 0.17
P/B ratio 0.33
Past 5Y EPS Growth —
This Y EPS Growth (1,100.00%) (below 0%: weak)
Next Y EPS Growth 33.33% (at or above 15%: strong)
Next Y revenue growth 47.83% (at or above 10%: strong)
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 0 0 5 0
Receivables 1 2 3 2
Inventory — — — —
Other — 1 0 0
1 3 8 3
2023 2024 2025 Q'26
Payables 3 9 12 6
ST’ Debt — — — —
Other 1 0 1 0
5 19 16 8

Compound Annual Growth %

10y 5y 3y
Sales — — —
Cash Flow — — 0.00%
Earnings — — 0.00%
Book Value — — 0.00%

Revenue $m

Mar Jun Sep Dec Year
’26 3 2 — — —
’25 3 1 4 6 15
’24 2 2 3 4 10
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (2) (1) — — —
’25 0 0 (1) (2) (3)
’24 1 (3) 0 (3) (6)
’23 0 0 0 0 (1)
’22 0 0 0 (1) (1)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (2) (1) — — —
’25 0 0 (1) (2) (3)
’24 1 (3) 0 (3) (6)
’23 0 0 0 0 (1)
’22 0 0 0 (1) (1)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (4.00) 0.80 — — —
’25 (19.20) (12.80) (1.60) (24.80) (58.40)
’24 1.63 (10.05) (274.40) (157.47) (452.00)
’23 (36.36) (7.39) (0.79) 14.73 (29.81)
’22 (2.83) (3.53) (4.40) (9.60) (20.36)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — — — 9.81 9.85 10.62 1.12 0.36

Analyst estimates 2026–2028

Powerpack
High — — — — — 9.89 11.00 14.49 33.08 2.52
People
People Employees — — — — — 2 2 2 154 209
Revenue/emp, $m — — — — — 0.00 0.00 2.88 0.07 0.07
Income, $m
Income, $m Revenue — — — — — — — 6 10 15
Gross margin, % — — — — — — — 66.47 68.87 50.32
EBT — — — — — 0 (3) (2) (59) (15)
EBT margin, % — — — — — 0.00 0.00 (32.73) (569.45) (100.18)
Net income — 0 — — — 0 (3) (4) (58) (15)
Depreciation — — — — — — — 0 58 3
Per share, $
Per share, $ Revenue — — — — — 0.00 0.00 46.13 81.61 58.05
Earnings — — — — — (6.55) (20.36) (29.81) (452.00) (58.40)
Cash flow — — — — — (12.05) (8.73) (5.06) (45.34) (13.68)
Capex — — — — — 0.00 0.00 (0.03) (0.43) (0.12)
Free cash flow — — — — — (12.05) (8.73) (5.10) (45.77) (13.80)
Book value — — — — — (66.96) (46.62) (34.40) (0.14) 21.65
Shares, m — — — — — 0 0 0 0 0
Valuation, ×
Valuation, × P/E — — — — — — — 0.00 0.00 0.00
P/S — — — — — — — 0.00 0.02 0.01
P/B — — — — — — — 0.00 0.00 0.02
EV/Sales — — — — — — — 0.00 0.04 (0.30)
EV/FCF — — — — — — — (2.21) (0.08) 1.25
Cash, $m
Cash, $m Operating cash flow — — — — — (1) (1) (1) (6) (3)
Capex — — — — — — — 0 0 0
Free cash flow — — — — — (1) (1) (1) (6) (3)
Balance, $m
Balance, $m Working capital — — — — — 1 (3) (4) (16) (8)
Total debt — — — — — — 1 — 1 1
Net debt — — — — — (1) 0 0 0 (5)
Shareholders’ equity — — — — — (3) (7) (4) 0 5
Returns, %
Returns, % ROA — — — — — (0.48) (5.16) (89.17) (554.87) (69.39)
ROIC — — — — — 0.00 0.00 0.00 (15,581.33) (767.86)
ROE — — — — — 0.00 60.26 64.18 2,672.63 (541.52)
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 2 Oct 2026

Charts ten years each

VSee Health, Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
MGRX Mangoceuticals, Inc. $7.1M — (loss-making) — −59.07% (below 0%: shrinking) n/m +79.27% (above 0%: growing) 64.24% (1,501.45%) Compare
HLTHQ Cue Health Inc. $6.9M — (loss-making) — (loss-making) −87.19% (below 0%: shrinking) n/m +50.55% (above 0%: growing) (90.14%) (792.13%) Compare
ZCMD Zhongchao Inc. $6.2M — (loss-making) — +20.44% (above 0%: growing) −550.00% (below 0%: shrinking) +191.85% (above 0%: growing) 41.67% 0.00% Compare
ACON Aclarion, Inc. $5.6M — (loss-making) — (loss-making) +30.57% (above 0%: growing) n/m −41.41% (below 0%: shrinking) 32.94% (11,506.75%) Compare
VSEED VSee Health, Inc. $2.8M — (loss-making) — (loss-making) +48.02% (above 0%: growing) n/m −257.62% (below 0%: shrinking) 13.20% (172.69%)
LGMK LogicMark, Inc. $1.7M — (loss-making) — (loss-making) +17.39% (above 0%: growing) n/m +96.41% (above 0%: growing) 70.71% (47.60%) Compare
MSPR MSP Recovery, Inc. $1.5M — (loss-making) — −94.60% (below 0%: shrinking) n/m +60.88% (above 0%: growing) (26.77%) (62,501.52%) Compare
MNDR Mobile-health Network Solutions $1.3M — — — — — — — Compare
WORX SCWorx Corp. $1.1M 0.1× — (loss-making) +3.43% (above 0%: growing) n/m +87.99% (above 0%: growing) 46.80% (17.14%) Compare
Median of peers $3.7M — — +3.43% — +79.27% 41.67% (792.13%)

All 51 Health Information Services stocks →

VSee Health, Inc. (VSEED) key facts

  • VSee Health, Inc. (VSEED) is a Health Information Services company in the Healthcare sector.
  • As of October 16, 2026, VSEED traded at $1.88, a market capitalization of $2.8 million.
  • Return on equity was −541.5% and debt-to-equity 0.10.
  • Its Piotroski F-score is 4 out of 9 and its Altman Z-score is −6.33 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations · fundamentals updated Oct 2, 2026.

VSee Health, Inc. (VSEED) Latest News

stockrow.com/VSEED · Data as of Oct 2, 2026 · For information only; not investment advice. · © 2026 stockrow.com